Choline transporters, cholinergic transmission and cognition

Nature Reviews Neuroscience

Volumn 6, Issue 1, 2005, Pages 48-56

  Sarter, Martin ^a   Parikh, Vinay ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL COENZYME A; ACETYLCHOLINE; ACETYLCHOLINESTERASE; CHOLINE; CHOLINE ACETYLTRANSFERASE; MUSCARINIC RECEPTOR; VESICULAR ACETYLCHOLINE TRANSPORTER;

BRAIN CORTEX; CHOLINE UPTAKE; CHOLINERGIC TRANSMISSION; COGNITION; DEGENERATIVE DISEASE; EXTRACELLULAR SPACE; HIPPOCAMPUS; HUMAN; MENTAL DISEASE; NERVE CELL PLASTICITY; NERVE ENDING; NEUROPSYCHIATRY; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; CHOLINE; CHOLINERGIC FIBERS; COGNITION; HUMANS; MEMBRANE TRANSPORT PROTEINS; SYNAPTIC TRANSMISSION;

EID: 11144243802     PISSN: 1471003X     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrn1588     Document Type: Review

References (96)

1. Posner, M. I. & Dehaene, S. Attentional networks. Trends Neurosci. 17, 75-79 (1994).
2. Wager, T. D., Jonides, J. & Reading, S. Neuroimaging studies of shifting attention: a meta-analysis. Neuroimage 22, 1679-1693 (2004).
3. Gaykema, R. P., van Weeghel, R., Hersh, L. B. & Luten, P. G. Prefrontal cortical projections to the cholinergic neurons in the basal forebrain. J. Comp. Neurol. 303, 563-583 (1991).
4. Edeline, J. M. The thalamo-cortical auditory receptive fields: regulation by the states of vigilance, learning and the neuromodulatory systems. Exp. Brain Res. 153, 554-572 (2003).
5. Sarter, M. & Bruno, J. P. Cognitive functions of cortical acetylcholine: toward a unifying hypothesis. Brain Res. Rev. 23, 28-46 (1997).
6. Zaborszky, L. The modular organization of brain systems. Basal forebrain: the last frontier. Prog. Brain Res. 136, 359-372 (2002). This paper provides a thought-provoking discussion in support of a modular organization of the forebrain cholinergic system.
7. Golmayo, L., Nunez, A. & Zaborszky, L. Electrophysiological evidence for the existence of a posterior cortical-prefrontal-basal forebrain circuitry in modulating sensory responses in visual and somatosensory rat cortical areas. Neuroscience 119, 597-609 (2003).
8. Nelson, C. L., Sarter, M. & Bruno, J. P. Prefrontal modulation of posterior parietal acetylcholine release: prefrontal glutamatergic and cholinergic mechanisms. Neuroscience (in the press).
9. Gill, T. M., Sarter, M. & Givens, B. Sustained visual attention performance-associated prefrontal neuronal activity: evidence for cholinergic modulation. J. Neurosci. 20, 4745-4757 (2000).
10. Sarter, M., Hasselmo, M. E., Bruno, J. P. & Givens, B. Unraveling the attentional functions of cortical cholinergic inputs: interactions between signal-driven and top-down cholinergic modulation of signal detection. Brain Res. Rev. (in the press).
11. Hasselmo, M. E. & McGaughy, J. High acetylcholine levels set circuit dynamics for attention and encoding and low acetylcholine levels set dynamics for consolidation. Prog. Brain Res. 145, 207-231 (2004).
12. Weinberger, N. M. Specific long-term memory traces in primary auditory cortex. Nature Rev. Neurosci. 5, 279-290 (2004).
13. Deutsch, J. A. The cholinergic synapse and the site of memory. Science 174, 788-794 (1971).
14. Drachman, D. A. Memory and cognitive function in man: does the cholinergic system have a specific role? Neurology 27, 783-790 (1977).
15. Everitt, B. J. & Robbins, T. W. Central cholinergic systems and cognition. Annu. Rev. Psychol. 48, 649-684 (1997). This paper reviews the pioneering research on the cognitive functions of the cholinergic system by these authors.
16. Sarter, M., Bruno, J. P. & Givens, B. Attentional functions of cortical cholinergic inputs: what does it mean for memory? Neurobiol. Learn. Mem. 80, 245-256 (2003).
17. Mesulam, M. The cholinergic lesion of Alzheimer's disease: pivotal factor or side show? Learn. Mem. 11, 43-49 (2004). This paper provides an up-to-date and balanced review of the evidence concerning the role of the cholinergic system in the cognitive decline of Alzheimer's disease.
18. Sarter, M. & Bruno, J. P. Developmental origins of the age-related decline in cortical cholinergic function and in associated cognitive abilities. Neurobiol. Aging 25, 1127-1139 (2004).
19. Sarter, M., Nelson, C. L. & Bruno, J. P. Cortical cholinergic transmission and cortical information processing following psychostimulant- sensitization: implications for models of schizophrenia. Schizophren. Bull. (in the press).
20. Misawa, H. et al. Distribution of the high-affinity choline transporter in the central nervous system of the rat. Neuroscience 105, 87-98 (2001).
21. Kus, L. et al. Distribution of high affinity choline transporter immunoreactivity in the primate central nervous system. J. Comp. Neurol. 463, 341-357 (2003).
22. Kuhar, M. J. & Murrin, L. C. Sodium-dependent, high affinity choline uptake. J. Neurochem. 30, 15-21 (1978).
23. Lockman, P. R. & Allen, D. D. The transport of choline. Drug Dev. Ind. Pharm. 28, 749-771 (2002).
24. Ferguson, S. M. & Blakely, R. D. The choline transporter resurfaces: new roles for synaptic vesicles? Mol. Intervent. 4, 22-37 (2004).
25. Atweh, S., Simon, J. R. & Kuhar, M. J. Utilization of sodium-dependent high affinity choline uptake in vitro as a measure of the activity of cholinergic neurons in vivo. Life Sci. 17, 1535-1544 (1975). This is one of the classic papers that describes original evidence for the role of CHTs in cholinergic transmission.
26. 3H]hemicholinium-3 binding sites in rat striatal slices. Eur. J. Pharmacol. 135, 35-40 (1987).
27. 3H]hemicholinium-3 in the rat brain: a potentially selective marker for presynaptic cholinergic sites. Life Sci. 35, 2335-2343 (1984).
28. Knipper, M., Kahle, C. & Breer, H. Regulation of hemicholinium binding sites in isolated nerve terminals. J. Neurobiol. 23, 163-172 (1992).
29. Ferguson, S. M. et al. Vesicular localization and activity-dependent trafficking of presynaptic choline transporters. J. Neurosci. 23, 9697-9709 (2003). This study generated seminal evidence in support of CHT trafficking as a mechanism to regulate CHT capacity.
30. Nakata, K., Okuda, T. & Misawa, H. Ultrastructural localization of high-affinity choline transporter in the rat neuromuscular junction: enrichment on synaptic vesicles. Synapse 53, 53-56 (2004).
31. Simon, J. R., Atweh, S. & Kuhar, M. J. Sodium-dependent high affinity choline uptake: a regulatory step in the synthesis of acetylcholine. J. Neurochem. 26, 909-922 (1976).
32. 3H]hemicholinium-3 binding sites in rat brain. Neuropharmacology 27, 1301-1308 (1988).
33. Cancela, J. M., Bertrand, N. & Beley, A. Involvement of cAMP in the regulation of high affinity choline uptake by rat brain synaptosomes. Biochem. Biophys. Res. Commun. 213, 944-949 (1995).
34. Gates, J., Ferguson, S. M., Blakely, R. D. & Apparsundaram, S. Regulation of choline transporter surface expression and phosphorylation by protein kinase C and protein phosphatase 1/2A. J. Pharmacol. Exp. Ther. 310, 536-545 (2004). This study shows that CHT is a phosphoprotein and that CHT trafficking is regulated by protein phosphatase1/2A.
35. Ribeiro, F. M. et al. The hemicholinium-3 sensitive high affinity choline transporter is internalized by clathrinmediated endocytosis and is present in endosomes and synaptic vesicles. J. Neurochem. 87, 136-146 (2003).
36. Okuda, T. et al. Identification and characterization of the high-affinity choline transporter. Nature Neurosci. 3, 120-125 (2000). This classic paper describes the first cloning of a CHT.
37. Apparsundaram, S., Ferguson, S. M., George, A. L. & Blakely, R. D. Molecular cloning of a human, hemicholinium-3-sensitive choline transporter. Biochem. Biophys. Res. Commun. 276, 862-867 (2000).
38. Ferguson, S. M. et al. Lethal impairment of cholinergic neurotransmission in hemicholinium-3-sensitive choline transporter knockout mice. Proc. Natl Acad Sci. USA 101, 8762-8767 (2004).
39. Brandon, E. P. et al. Choline transporter 1 maintains cholinergic function in choline acetyltransferase haploinsufficiency. J. Neurosci. 24, 5459-5466 (2004).
40. Volpicelli-Daley L. A. et al. Altered striatal function and muscarinic cholinergic receptors in acetylcholinesterase knockout mice. Mol. Pharmacol. 64, 1309-1316 (2003).
41. Beeri, R. et al. Enhanced hemicholinium binding and attenuated dendrite branching in cognitively impaired acetylcholinesterase-transgenic mice. J. Neurochem. 69, 2441-2451 (1997).
42. Okuda, T., Okamura, M., Kaitsuka, C., Haga, T. & Gurwitz, D. Single nucleotide polymorphism of the human high affinity choline transporter alters transport rate. J. Biol. Chem. 277, 45315-45322 (2002).
43. Dalley, J. W. et al. Distinct changes in cortical acetylcholine and noradrenaline efflux during contingent and noncontingent performance of a visual attentional task. J. Neurosci. 21, 4906-4914 (2001).
44. Arnold, H. M., Burk, J. A., Hodgson, E. M., Sarter, M. & Bruno, J. P. Differential cortical acetylcholine release in rats performing a sustained attention task versus behavioral control tasks that do not explicitly tax attention. Neuroscience 114, 451-460 (2002).
45. Burmeister, J. J., Moxon, K. & Gerhardt, G. A. Ceramic-based multisite microelectrodes for electrochemical recordings. Anal. Chem. 72, 187-192 (2000).
46. Burmeister, J. J., Palmer, M. & Gerhardt, G. A. Ceramic-based multisite electrode array for rapid choline measures in brain tissue. Anal. Chim. Acta 481, 65-74 (2003). This paper was the first to describe the measurement of choline by an amperometric method involving enzyme-coated, multi-site ceramic-based microelectrodes.
47. Burmeister, J, J. & Gerhardt, G. A. Ceramic-based multisite microelectrode arrays for in vivo electrochemical recordings of glutamate and other neurochemicals. Trends in Anal. Chem. 22, 497-502 (2003).
48. Parikh, V. et al. Rapid assessment of in vivo cholinergic transmission by amperometric detection of changes in extracellular choline levels. Eur. J. Neurosci. 20, 1545-1554 (2004).
49. Hagan, J. J., Jansen, J. H. & Broekkamp, C. L. Hemicholinium-3 impairs spatial learning and the deficit is reversed by cholinomimetics. Psychopharmacology (Berl.) 98, 347-356 (1989).
50. Decker, M. W., Pelleymounter, M. A. & Gallagher, M. Effects of training on a spatial memory task on high affinity choline uptake in hippocampus and cortex in young adult and aged rats. J. Neurosci. 8, 90-99 (1988).
51. Durkin, T. P. Spatial working memory over long retention intervals: dependence on sustained cholinergic activation in the septohippocampal or nucleus basalis magnocellularis-cortical pathways? Neuroscience 62, 681-693 (1994).
52. Toumane, A., Durkin, T., Marighetto, A. & Jaffard, R. The durations of hippocampal and cortical cholinergic actuation induced by spatial discrimination testing of mice in an eight-arm radial maze decrease as a function of acquisition. Behav. Neural Biol. 52, 279-284 (1989).
53. 3H]choline into acetylcholinergic neurons of the nucleus basalis magnocellularis and medial septal area. Behav. Brain Res. 13, 129-138 (1984).
54. McGaughy, J., Kaiser, T. & Sarter, M. Behavioral vigilance following infusions of 192 IgG-saporin into the basal forebrain: selectivity of the behavioral impairment and relation to cortical AChE-positive fiber density. Behav. Neurosci. 110, 247-265 (1996). This study shows that selective lesions of cortical cholinergic inputs are sufficient to produce specific and persistent impairments in attention performance.
55. Apparsundaram, S. et al. Choline transporter regulation in cognition: attention performance-induced increases in maximal choline transporter velocity in the right, but not left, frontal cortex. Soc. Neurosci. Abstr. 30, 949.7 (2004).
56. Martinez, V. & Sarter, M. Lateralized attentional functions of cortical cholinergic inputs. Behav. Neurosci. 118, 984-991 (2004).
57. Posner, M. I. & Petersen, S. E. The attention system of the human brain. Annu. Rev. Neurosci. 13, 25-42 (1990).
58. Pardo, J. V., Fox, P. T. & Raichle, M. E. Localization of a human system for sustained attention by positron emission topography. Nature 349, 61-64 (1991).
59. Lawrence, N. S., Ross, T. J., Hoffmann, R., Garavan, H. & Stein, E. A. Multiple neuronal networks mediate sustained attention. J. Cogn. Neurosci. 15, 1028-1038 (2003).
60. Bentley, P., Vuilleumier, P., Thiel, C. M., Driver, J. & Dolan, R. J. Cholinergic enhancement modulates neural correlates of selective attention and emotional processing. Neuroimage 20, 58-70 (2003).
61. Furey, M. L., Pietrini, P. & Haxby, J. V. Cholinergic enhancement and increased selectivity of perceptual processing during working memory. Science 290, 2315-2319 (2000).
62. Chu, Y., Cochran, E. J., Bennett, D. A., Mufson, E. J. & Kordower, J. H. Downregulation of trkA mRNA within nucleus basalis neurons in individuals with mild cognitive impairment and Alzheimer's disease. J. Comp. Neurol. 437, 296-307 (2001).
63. Mufson, E. J. et al. Loss of basal forebrain P75(NTR) immunoreactivity in subjects with mild cognitive impairment and Alzheimer's disease. J. Comp. Neurol. 443, 136-153 (2002).
64. Mufson, E. J. et al. Loss of nucleus basalis neurons containing trkA immunoreactivity in individuals with mild cognitive impairment and early Alzheimer's disease. J. Comp. Neurol. 427, 19-30 (2000).
65. Mufson, E. J., Ginsberg, S. D., Ikonomovic, M. D. & DeKosky, S. T. Human cholinergic basal forebrain: chemoanatomy and neurologic dysfunction. J. Chem. Neuroanat. 26, 233-242 (2003).
66. Slotkin, T. A. et al. Regulatory changes in presynaptic cholinergic function assessed in rapid autopsy material from patients with Alzheimer disease: implications for etiology and therapy. Proc. Natl Acad. Sci. USA 87, 2452-2455 (1990).
67. Slotkin, T. A., Nemeroff, C. B., Bissette, G. & Seidler, F. J. Overexpression of the high affinity choline transporter in cortical regions affected by Alzheimer's disease. Evidence from rapid autopsy studies. J. Clin. Invest. 94, 696-702 (1994).
68. Auld, D. S., Kornecook, T. J., Bastianetto, S. & Quirion, R. Alzheimer's disease and the basal forebrain cholinergic system: relations to β-amyloid peptides, cognition, and treatment strategies. Prog. Neurobiol. 68, 209-245 (2002).
69. Kar, S. et al. Amyloid-β peptide inhibits high-affinity choline uptake and acetyicholine release in rat hippocampal slices. J. Neurochem. 70, 2179-2187 (1998).
70. Hartmann, J. et al. Central cholinergic functions in human amyloid precursor protein knock-in/presenilin-1 transgenic mice. Neuroscience 125, 1009-1017 (2004).
71. Xie, J. & Quo, Q. Par-4 inhibits choline uptake by interacting with CHT1 and reducing its incorporation on the plasma membrane. J. Biol. Chem. 279, 28266-28275 (2004).
72. Guo, Q. et al. Par-4 is a mediator of neuronal degeneration associated with the pathogenesis of Alzheimer disease. Nature Med. 4, 957-962 (1998).
73. Wurtman, R. J. Choline metabolism as a basis for the selective vulnerability of cholinergic neurons. Trends Neurosci. 15, 117-122 (1992). This paper discusses the author's influential hypothesis that postulates that the dual use of choline for ACh and phosphatidylcholine synthesis contributes to the vulnerability of cholinergic neurons in Alzheimer's disease.
74. Maire, J. C. & Wurtman, R. J. Choline production from choline-containing phospholipids: a hypothetical role in Alzheimer's disease and aging. Prog. Neuropsychopharmacol. Biol. Psychiatry 8, 637-642 (1984).
75. Higgins, J. P. & Flicker, L. Lecithin for dementia and cognitive impairment. Cochrane Database Syst. Rev. CD001015 (2003).
76. Floyd, E. A. et al. Chronic ethanol ingestion produces cholinergc hypofunction in rat brain. Alcohol 14, 93-98 (1997).
77. De Rosa, E., Desmond, J. E., Anderson, A. K., Ptefferbaum, A. & Sullivan, E. V. The human basal forebrain integrates the old and the new. Neuron 41, 825-837 (2004).
78. Nelson, C. L., Sarter, M. & Bruno, J. P. Repeated pretreatment with amphetamine sensitizes increases in cortical acetylcholine release. Psychopharmacology (Berl.) 151, 406-415 (2000).
79. Laplante, F., Srivastava, L. K. & Quirion, R. Alterations in dopaminergic modulation of prefrontal cortical acetylcholine release in post-pubertal rats with neonatal ventral hippocampal lesions. J. Neurochem. 89, 314-323 (2004).
80. Hyde, T. M. & Crook, J. M. Cholinergic systems and schizophrenia: primary pathology or epiphenomena? J. Chem. Neuroanat. 22, 53-63 (2001).
81. Raedler, T. J. et al. In vivo determination of muscarinic acetylcholine receptor availability in schizophrenia. Am. J. Psychiatry 160, 118-127 (2003).
82. Moore, H., Fadel, J., Sarter, M. & Bruno, J. P. Role of accumbens and cortical dopamine receptors in the regulation of cortical acetylcholine release. Neuroscience 88, 811-822 (1999).
83. Volkow, N. D., Ding, Y. S., Fowler, J. S. & Gatley, S. J. Imaging brain cholinergic activity with positron emission topography: its role in the evaluation of cholinergic treatments in Alzheimer's dementia. Biol. Psychiatry 49, 211-220 (2001).
84. Gray, J. R. & Thompson, P. M. Neurobiology of intelligence: science and ethics. Nature Rev. Neurosci. 5, 471-482 (2004).
85. Szekeres, G. et al. Role of dopamine D3 receptor (DRD3) and dopamine transporter (DAT) polymorphism in cognitive dysfunctions and therapeutic response to atypical antipsychotics in patients with schizophrenia. Am. J. Med. Genet. 124B, 1-5 (2004).
86. Heils, A., Mossner, R. & Lesch, K. P. The human serotonin transporter gene polymorphism - basic research and clinical implications, J. Neural Transm. 104, 1005-1014 (1997).
87. Stahl, S. M. Neurotransmission in cognition, part 3. Mechanism of action of selective NRIs: both dopamine and noradrenaline increases in prefrontal cortex. J. Clin. Psychiatry 64, 230-231 (2003).
88. Blusztajn, J. K. Choline, a vital amine. Science 281, 794-795 (1998).
89. Wurtman, R. J., Regan, M., Ulus, I. & Yu, L. Effect of oral CDP-choline and uridine levels in humans. Biochem. Pharmacol. 60, 989-992 (2000).
90. James, W. The Principles of Psychology (Dover, New York, 1890).
91. Parasuraman, R. & Davis, D. R. Varieties of Attention (Academic, Orlando, 1984).
92. Robbins, T. W. The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry. Psychopharmacology (Berl.) 163, 362-380 (2002).
93. McGaughy, J. & Sarter, M. Behavioral vigilance in rats: task validation and effects of age, amphetamine, and benzodiazepine receptor ligands. Psychopharmacology (Berl.) 117, 340-357 (1995).
94. Bushnell, P. J., Benignus, V. A. & Case, M. W. Signal detection behavior in humans and rats: a comparison with matched tasks. Behav. Processes 64, 121-129 (2003).
95. Turchi, J. & Sarter, M. Cortical acetylcholine and processing capacity: effects of cortical Cholinergic deafferentation on crossmodal divided attention in rats. Cogn. Brain Res. 6, 147-158 (1997).
96. Kozak, R., Jewell, B. S., Crum, J. M., Bruno, J. P. & Sarter, M. What drives cortical acetylcholine release? ACh release during impairment and recovery of sustained attention performance, produced by basal forebrain NMDA receptor blockade. Soc. Neurosci. Abstr. 30, 780.3 (2004).